
Equifax wiped out his credit score — and a little-known policy means he can't get it back
Social Sharing
David Tregear says getting credit was never a problem, until the rejections started piling up. A car loan, credit cards and more — all denied.
When he checked his Equifax account, he saw his score had been wiped to zero — without warning or explanation.
" I was just stunned," said the Victoria man. "I was like, what do you mean I don't have credit? Are you kidding me?"
What followed was more than a year of frustration.
Tregear says he begged Equifax to fix the problem — sending documents, filing complaints, even turning to federal and provincial oversight bodies for help. Nothing worked.
Equifax refused to restore his credit score or explain why it dropped to zero, until Go Public started asking questions.
Only then did the company point to its little-known policy: If a credit file sits inactive, the consumer may be labelled "unscoreable" and their score reset to zero. Tregear says the last time he checked, before it disappeared, his score was around a more respectable 700.
He says it's true that he stopped using credit to avoid falling into debt, but never imagined he'd be penalized for it.
Equifax told him it's a two year cutoff, but won't say if that's true for everyone.
Canada's other major credit bureau, TransUnion, says it doesn't reset credit scores.
A credit score is a number that typically ranges from 300 to 900 and shows lenders how likely you are to repay debt.
Tregear says the consequences have been serious — especially since many lenders rely solely on Equifax.
WATCH | Reset to zero:
Equifax customer fights to restore credit after score vanishes | Go Public
13 hours ago
Duration 2:15
Equifax customer David Tregear has spent over a year battling the company after his credit score suddenly vanished, leaving him unable to borrow money or get credit cards. Tregear had no idea why until CBC's Go Public uncovered a little-known rule allowing the credit bureau to reset credit scores to zero — a rule consumer experts say lacks transparency and oversight.
"This has to be rectified somehow," he said.
Equifax told him he'll have to rebuild his credit score from scratch — a challenge, he says, since he can't get approved for credit without one.
Serious flaws
Go Public has since found a major flaw in consumer protection rules — that there are no laws or oversight on how credit scores are calculated, leaving credit bureaus to do what they want.
Consumer advocate Geoff White says that gives credit bureaus too much power, with no transparency.
"A credit score is a very important piece of information. It shouldn't be arbitrarily wiped out through lack of use of credit," said White, executive director of the Public Interest Advocacy Centre, a non-profit that advocates for consumer rights.
"The customer is out of luck," he says. "This shows there's a hole in Canada's consumer protection system when it comes to credit."
Equifax says its website is clear about how scores are calculated — citing factors like payment history, available credit and public records. But it also says having different scores from Equifax and TransUnion is "completely normal," because each bureau uses "multiple scoring algorithms," and that "there are some differences in the calculations."
Equifax refused to answer Go Public's specific questions about Tregear's case, how it justifies deleting a consumer's long-standing credit score due to inactivity, or how that policy affects Canadians.
Instead, it sent a general statement partly saying it takes "consumer concerns very seriously" and "prides itself on being a trusted steward of personal data" and is "committed to maintaining the accuracy of all credit data… in compliance with applicable legislation."
Tregear says the reset has left him stuck — unable to get credit or buy a home — because many lenders only check Equifax. He says every time he opened a complaint, Equifax closed it without resolving anything.
"They've never reached out to me," he said. "I've always had to call in and with no success. I started feeling defeated."
Equifax's website mentions the policy, saying: "Sometimes there's not enough information in your credit file to provide a credit score… This is not an indicator of bad credit history."
But White, and other credit experts, tell Go Public that's just not the case.
"A zero credit score means you're starting from scratch," he said. "Credit scores influence not only the decision to lend or not lend… it affects your ability to get a good interest rate on your mortgage."
The Financial Consumer Agency of Canada (FCAC) also flags the issue on its website: "It's impossible to know exactly how much your credit score will change based on the actions you take. Credit bureaus and lenders don't share the actual formulas it uses to calculate credit scores."
Go Public asked Equifax about transparency concerns. It didn't respond.
Bureaucratic maze
Tregear says trying to get help felt like being stuck in a bureaucratic maze.
He's written letters, made countless phone calls, and even filed complaints with both provincial and federal regulators — but got no help.
"Everybody was just referring me back to somebody else or referring back to the same person that referred me to them," Tregear said.
He tried the Office of the Superintendent of Financial Institutions, which referred him to the FCAC, which said it doesn't handle complaints about credit bureaus.
Then he was sent to Consumer Protection B.C., which said it was outside their mandate, and he should contact the privacy commissioner — but it wasn't clear whether that meant the federal or provincial office.
"It's been crazy," Tregear said.
White says when things go wrong — like in Tregear's case — the complaints process can be "tortuous."
He says Tregear's case shows the maze consumers face with no clear path forward.
"It tells me there's a lack of common-sense rules," said White. "This is a big problem."
He says Ottawa can — and should — step in and create consistent national standards by regulating credit bureaus under the Bank Act, rather than leaving oversight to provinces with a patchwork of regulations.
While banks fall under federal regulation, credit bureaus are overseen by provincial agencies — and rules can vary depending on where you live.
In general, provinces make sure credit reports follow basic rules like getting consent before someone accesses your report, addressing false information and overseeing privacy like how personal data is collected, used and shared.
But credit scores are a different story. No government agency regulates how they're calculated — or whether they're fair. Credit bureaus, which are private companies, make their own rules.
"Credit reporting… needs an overhaul and we need clear federal rules that allow for accountability and more transparency in terms of how this process works and how life-affecting decisions are made," said White.
Go Public asked Finance Minister François-Philippe Champagne if he plans to step in — but got no response. The ministry would only say credit bureaus aren't under federal control.
'Punished for living debt-free'
Equifax says it is already "a highly regulated business… governed by both applicable credit reporting and privacy laws in Canada. To protect the integrity of our processes, procedures and to ensure we comply with applicable law, we do not allow for public comment on consumer inquiries."
After Go Public brought Tregear's case to their attention, two B.C. agencies — Consumer Protection B.C. and the provincial privacy commissioner — reached out to him offering to investigate.
He'd contacted the wrong privacy office — the federal one — by mistake, and Consumer Protection B.C. had wrongly turned him away. That agency now admits it "overlooked" some jurisdictional issues and says it's reviewing its processes to make sure it doesn't happen again.
But Tregear says he doubts he'll get the help he needs — especially with Equifax's little-known policy still in place.
"I'm being punished for living debt-free," he said.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CBC
an hour ago
- CBC
Alberta asks for a West Coast pipeline as a nation-building project
The federal government has tabled a signature piece of legislation designed to invest in what Prime Minister Carney is referring to as 'nation-building projects.' The CBC's Sam Brooks takes us into how the Alberta government is responding.


Globe and Mail
an hour ago
- Globe and Mail
Hims & Hers Stock Is Soaring Again. But Should You Buy the Stock?
Many companies have failed to disrupt the complicated U.S. healthcare market. Hims & Hers (NYSE: HIMS) may finally be succeeding in cracking the code. The online telehealth platform focuses on circumventing the insurance market; its business of selling affordable medications directly to individuals is growing like a weed, and expects to generate $6.5 billion in revenue by 2030. It has had a tumultuous start to 2025, as Hims & Hers waged a battle to sell new weight loss medications on its online marketplace. Now, with momentum back on its side, the stock is up 118% year to date and 446% in the last five years. Let's take a deeper look at this company, and see whether you might want to buy Hims & Hers stock for your portfolio now. Disrupting the healthcare market Hims & Hers' model is simple. It has two separate web platforms -- Hims for men and Hers for women -- that sell medications and deliver to customers' front doors. It began with sexual health, but has moved into dermatology, hair loss, mental health, and now weight loss medications. A key to its success has been avoiding the insurance market with products that don't break the bank. Customers loathe dealing with health insurers in the United States, and sometimes would rather not use insurance at all. Plus, some of these products aren't covered by insurance. This strategy has helped the company close in on over $2 billion in projected revenue in 2025. To keep up this impressive growth, Hims & Hers wants to offer weight loss medications, which have been a blockbuster set of drugs for the pharmaceutical market. For a while the popularity of these drugs, such as Novo Nordisk 's Wegovy, left them in short supply; that allowed third parties such as Hims & Hers to produce them as a compounding pharmacy and sell them at much cheaper prices. This ended up generating $200 million of Hims & Hers' $1.4 billion in 2024 revenue. But with the shortage of Wegovy over and the compounding pharmacy exception ended, the company's weight-loss business was at a major turning point. Luckily, at the end of April Hims & Hers announced a partnership with Novo Nordisk that seems to resolve this issue: It gives Hims & Hers the ability to sell Wegovy directly on its platform. Hims & Hers is not an exclusive supplier of the drug -- or any drugs on its marketplaces, to be fair -- but it hopes to use its subscription business model, marketing expertise, and simplified user proposition to drive sales for Novo Nordisk in the huge obesity-care market. Going abroad and personalization Besides weight loss drugs, Hims & Hers has more ambitions to reach its goal of $6.5 billion in revenue by 2030. Just recently, the company announced its intent to acquire European competitor Zava so it could expand its telehealth service to Europe. The acquisition will add a platform with 1.3 million active customers in the U.K., Germany, France, and Ireland. It makes sense that Hims & Hers can supercharge growth for the platform with its plethora of medications offered to customers, keen marketing skills, and subscription-based selling model. Over the long run, Hims & Hers aims to make healthcare for its customers more personalized. This includes unique drug combinations, its own outsourcing facility, and at-home testing capabilities. Details remain sparse, but the vision is clear: disrupting more and more of the trillions of dollars spent on healthcare by building a business that people actually enjoy interacting with. This is why 2.4 million active customers use Hims & Hers today. HIMS Gross Profit Margin data by YCharts. Should you buy Hims & Hers stock? A revenue goal of $6.5 billion seems well within reach by 2030. Hims & Hers is only at 2.4 million active customers, and there are tens of millions of people in the United States alone who could start using or switch to one of its telehealth platforms. Add on the Zava acquisition in Europe, and the runway for growth gets even larger. The company has an impressive gross profit margin of 77%, which should lead to high levels of profitability at scale. On $6.5 billion in future revenue, it could very well post a net profit margin of over 20%, and achieve $1.5 billion in bottom-line profits and free cash flow. A 20% profit margin is easily achievable because of its high gross margins and the fact it currently spends 40% of revenue on marketing today, a figure that has come down over time and should come down even more as Hims & Hers keeps scaling. However, Hims & Hers has played fast and loose with laws and regulations in the past. It sold weight loss drugs when the legality of doing so was unclear, and although that dispute seems to have been resolved, management could easily start playing with fire again and burn its reputation as a trusted provider of medications. Otherwise, this looks like a fantastic growth stock that just doubled its addressable market with the Zava acquisition. Today, Hims & Hers has a market cap of $12.3 billion. You might think it's overvalued because of the stock's recent run-up in price, but the numbers show that patient investors could be rewarded by holding for the long term. A $12.3 billion market cap is only around 8 times my 2030 earnings estimate of $1.5 billion, which would be a dirt cheap price-to-earnings (P/E) ratio for a fast-growing company compared to the current market cap. Most likely, the stock will be valued at a higher multiple than 8, meaning that the stock will be higher in five years. It doesn't come without risks, but if you're a growth investor, you might love Hims & Hers stock for its long-term potential. Should you invest $1,000 in Hims & Hers Health right now? Before you buy stock in Hims & Hers Health, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Hims & Hers Health wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $669,517!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $868,615!* Now, it's worth noting Stock Advisor 's total average return is792% — a market-crushing outperformance compared to173%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 2, 2025


Globe and Mail
2 hours ago
- Globe and Mail
Better Artificial Intelligence (AI) Stock: CoreWeave vs. Nvidia
There will prove to be many winners as artificial intelligence (AI) infrastructure continues to grow and AI end-uses expand. Nvidia (NASDAQ: NVDA) has been the Wall Street darling surrounding everything AI for the past two years. CoreWeave (NASDAQ: CRWV) has been getting the love most recently, though. Shares of the AI hyperscaler providing cloud services have soared about 185% in just the past month as of this writing. Nvidia stock has increased 24% in that time. CoreWeave just went public in late March, and the shares have jumped about 270% since that initial public offering (IPO). Investors may wonder if Nvidia's shine is fading, and it's time to buy CoreWeave instead. I'd argue that is flawed thinking, however. The growth isn't over for Nvidia Investors may be taking a breather after the early exponential gains in Nvidia stock. Growth in the business itself has also slowed, though that was inevitable. Sales of its advanced chips in the data center segment had been growing like a weed. Revenue in that segment has been increasing in each consecutive quarter for the last two years. In the most recent fiscal quarter, that growth rate slowed to 10%, though, as seen below. Despite that trend, it's clear AI demand hasn't yet peaked. Remember, these are still sequential quarterly increases in data center sales. For perspective, that fiscal first-quarter revenue was a 73% jump compared to the prior year period. Management also guided investors to expect further revenue growth in the current quarter. So, while an unsustainable growth rate slows, the company is still solidly in growth mode. Nvidia is more ubiquitous than you might think That's because it's not just Nvidia's advanced GPU and CPU chips driving sales and expanding AI infrastructure. Its AI ecosystem includes interconnect technologies, the CUDA (compute unified device architecture) software platform, and artificial intelligence processors that are part of many different types of architectures. CEO Jensen Huang recently touted Nintendo 's new Switch 2 gaming console, for example. The unit includes Nvidia's AI processors that Huang claims "sharpen, animate, and enhance gameplay in real time." Nvidia has a broad array of customers. As AI factories and data centers are built, it will continue to be a major supplier and one that investors should benefit from owning. Nvidia also invests in the AI sector. It makes sense to look at where the AI leader itself sees future gains. Nvidia thinks CoreWeave is a good investment One of the AI companies in which Nvidia holds a stake is CoreWeave. Nvidia should know CoreWeave well, too, as an important customer. CoreWeave leases data center space to companies needing the scalable, on-demand compute power it has control of from the 250,000 Nvidia chips it has purchased. It's a desirable option for enterprises that require significant computational power to process large amounts of data efficiently. There appears to be plenty of demand. But there is plenty of risk for investors, too. It just announced a new lease agreement to further increase capacity. Applied Digital, a builder and operator of purpose-built data centers, has agreed to deliver CoreWeave 250 megawatts (MW) of power load on a 15-year term lease at its recently built North Dakota data center campus. CoreWeave has the option to expand the load by an additional 150 MW in the future. Demand is quickly driving growth for CoreWeave. That's led investors to jump in and drive the stock higher in recent months. Valuation is just one major risk with CoreWeave. Customer concentration is another. Last year, Microsoft accounted for nearly two-thirds of revenue. CoreWeave also disclosed that 77% of 2024 revenue came from just its top two customers. CoreWeave is also spending massive amounts of capital to grow AI cloud capacity. It had about $5.4 billion of liquidity available as of March 31 and raised another $2 billion from a late May debt offering. That's approximately its level of capital expenditure in just the first quarter alone, though. CoreWeave has the risk, Nvidia has the profits That spending may pay off. But there are risks there as well. Customers could develop their own AI infrastructure or could redesign systems that don't require its services. CoreWeave stock also trades at a high valuation after the stock has soared. It recently had a price-to-sales (P/S) ratio of about 30. That could be cut in half this year with its strong sales growth, but it isn't earning any money yet. At the same time, Nvidia sports a price-to- earnings (P/E) ratio of about 30 based on this year's expected profits. Remember, too, that as CoreWeave grows, so do Nvidia's profits. Applied Digital CEO Wes Cummins said that its leased North Dakota data center campus will be full of Nvidia Blackwell class servers. I think the risk profile, financial picture, and massive potential for Nvidia make it the better AI stock to buy now. Should you invest $1,000 in Nvidia right now? Before you buy stock in Nvidia, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Nvidia wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $669,517!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $868,615!* Now, it's worth noting Stock Advisor 's total average return is792% — a market-crushing outperformance compared to173%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 2, 2025